Prognostic Impact of KRAS Mutation Subtypes in 677 Patients with Metastatic Lung AdenocarcinomasHelena A. Yu, Gregory J. Riely, Geoffrey R. Oxnard et al.|Journal of Thoracic Oncology|2014Cited by 138
Correlation between KRAS mutation status and response to chemotherapy in patients with advanced non-small cell lung cancer☆Megan Hames, Leora Horn, Jonathan Aston et al.|Lung Cancer|2015Cited by 66